Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Barinthus Biotherapeutics (NASDAQ:BRNS) through any online brokerage.
There are no as such competitors for Barinthus Biotherapeutics.
Barinthus Biotherapeutics has a consensus price target of $5.50.
The stock price for Barinthus Biotherapeutics (NASDAQ: BRNS) is $0.6013 last updated June 5, 2026 at 7:37 PM EDT.
There are no upcoming dividends for Barinthus Biotherapeutics.
Barinthus Biotherapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Barinthus Biotherapeutics.
Barinthus Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.